tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Caitlin Cronin, 44 are a BUY (67.69%), 21 are a HOLD (32.31%).
Analyst Caitlin Cronin, currently employed at CANACCORD, carries an average stock price target met ratio of 52.34% that have a potential upside of 29.46% achieved within 112 days.
Caitlin Cronin’s has documented 127 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BVS, Bioventus at 17-Aug-2026.
Analyst best performing recommendations are on KRMD (REPRO MED SYSTEMS).
The best stock recommendation documented was for SNN (SMITH & NEPHEW SNATS) at 5/11/2026. The price target of $30 was fulfilled within 1 day with a profit of $0.9 (3.09%) receiving and performance score of 30.93.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2026
$16
$5.97 (59.52%)
$15
2 months 3 days ago
(05-Aug-2026)
0/2 (0%)
$6.43 (67.19%)
Buy Since 19-Oct-2020
$13
$2.97 (29.61%)
$11
2 months 3 days ago
(05-Aug-2026)
6/10 (60%)
$3.43 (35.84%)
255
Buy Since 01-Aug-2024
$12
$1.97 (19.64%)
$11
2 months 3 days ago
(05-Aug-2026)
2/4 (50%)
$2.43 (25.39%)
234
Buy Since 09-Mar-2026
$13
$2.97 (29.61%)
$20
3 months ago
(08-Jul-2026)
1/4 (25%)
$3.79 (41.15%)
13
Buy Since 05-Aug-2019
$14
$3.97 (39.58%)
$14
4 months 10 days ago
(28-May-2026)
19/23 (82.61%)
$6.11 (77.44%)
542
Which stock is Caitlin Cronin most bullish on?
Which stock is Caitlin Cronin most reserved on?
What Year was the first public recommendation made by Caitlin Cronin?
